October 26, 2020
Home  »  Website  »  National  »  Independence Day Speech: PM Modi Says 3 Covid Vaccines At Trials, Plan For Distribution Ready

Independence Day Speech: PM Modi Says 3 Covid Vaccines At Trials, Plan For Distribution Ready

Addressing the nation from the ramparts of the Red Fort on India's 74th Independence Day, PM Modi said a roadmap has been prepared to ensure that the Covid vaccine reaches everyone in the country in the shortest possible time with mass production

Google + Linkedin Whatsapp
Follow Outlook India On News
Independence Day Speech: PM Modi Says 3 Covid Vaccines At Trials, Plan For Distribution Ready
Prime Minister Narendra Modi addresses the nation during the 74th Independence Day celebrations, at Red Fort in New Delhi.
PTI Photo
Independence Day Speech: PM Modi Says 3 Covid Vaccines At Trials, Plan For Distribution Ready
outlookindia.com
2020-08-15T12:26:51+05:30

Prime Minister Narendra Modi on Saturday said mass production of vaccine for COVID-19 will begin in India once scientists give their nod, and a roadmap was ready to ensure it reaches everyone in the country in the shortest possible time.

Addressing the nation from the ramparts of the Red Fort on India's 74th Independence Day, Modi said three vaccine candidates are in different stages of trials in the country, adding the talent of our scientists is like that of 'rishi munis'.

He said whenever there is talk of COVID-19, the question that comes to everyone's mind is that when will a vaccine be ready.

"I want to tell people, the talent of our scientists is like that of 'rishi munis' and they are working very hard in laboratories. Three vaccines are in various stages of testing. When scientists will give us the green signal, there will be production on a mass scale and all preparations have been made for it," Modi said.

A roadmap has been prepared to ensure that the vaccine reaches everyone in the country in the shortest possible time with mass production, he said.

Three vaccine candidates are in different stages of human clinical trials in India.

The phase-1 and 2 human clinical trials of two of them, developed indigenously by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR), and Zydus Cadila Ltd, are currently underway.

The Serum Institute of India has been permitted for conducting Phase 2 and 3 human clinical trials of the third vaccine candidate developed by the Oxford University. The Pune-based institute has partnered with AstraZeneca for manufacturing the vaccine.


For in-depth, objective and more importantly balanced journalism, Click here to subscribe to Outlook Magazine
Next Story >>
Google + Linkedin Whatsapp

The Latest Issue

Outlook Videos